ARRY-382

ARRY-382 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARRY-382, covering 2022-06-16 to 2022-06-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing